Experimental models allow the systematic study of urological malignancies in in vitro cellular environments and in vivo animals. Models can be pure clones of animal-derived cancer cells, immortalized by genetic manipulations, and maintained in monolayer or co-cultured with non-cancer cells in biocompatible 3-D scaffolds. Immortalized cells may be ectopically or orthotopically allo- or xeno-transplanted into animal hosts, where they establish primary tumours and metastases. Additionally, animals may be genetically-engineered to develop autochthonous tumours thus mimicking cancer initiation and progression in humans. The above sequentially-complex models allow the study of cancer cell and tumour biology, as well as chemopreventative, anticanc...
Each year more than 65,000 people are diagnosed with urinary bladder cancer, and more than 14,000 pe...
Urotelial cancer, is a common malignancy in the worldwide, is an important contributor to the overal...
Bladder cancer is a common malignancy that has a relatively poor outcome. Lack of culture models for...
Urinary bladder cancer (UBC) is a heterogeneous disease with highly variable clinical outcomes and r...
Transitional cell carcinoma (TCC) is the most common malignancy of the genitourinary tract and TCC m...
Genomic analyses are defining numerous new targets for cancer therapy. Therapies aimed at specific g...
The development of advanced tumor models has long been encouraged because current cancer models have...
The number of patients diagnosed with prostate and bladder cancer is increasing worldwide and one of...
Urological malignancies, including prostate and bladder carcinoma, represent a major clinical proble...
Urological malignancies, including prostate and bladder carcinoma, represent a major clinical proble...
For the evaluation of anti-human bladder cancer immunotoxin approaches, the orthotopic nude murine m...
Bladder cancer is the fifth most common cancer in the UK, yet human bladder carcinogenesis remains p...
Bladder cancer (BC) constitutes approximately 2% of all spontaneously occurring cancers in dogs. It ...
The therapeutic use of stem cells and tissue engineering techniques are emerging in urology. Here, s...
Urological malignancies, including prostate and bladder carcinoma, represent a major clinical proble...
Each year more than 65,000 people are diagnosed with urinary bladder cancer, and more than 14,000 pe...
Urotelial cancer, is a common malignancy in the worldwide, is an important contributor to the overal...
Bladder cancer is a common malignancy that has a relatively poor outcome. Lack of culture models for...
Urinary bladder cancer (UBC) is a heterogeneous disease with highly variable clinical outcomes and r...
Transitional cell carcinoma (TCC) is the most common malignancy of the genitourinary tract and TCC m...
Genomic analyses are defining numerous new targets for cancer therapy. Therapies aimed at specific g...
The development of advanced tumor models has long been encouraged because current cancer models have...
The number of patients diagnosed with prostate and bladder cancer is increasing worldwide and one of...
Urological malignancies, including prostate and bladder carcinoma, represent a major clinical proble...
Urological malignancies, including prostate and bladder carcinoma, represent a major clinical proble...
For the evaluation of anti-human bladder cancer immunotoxin approaches, the orthotopic nude murine m...
Bladder cancer is the fifth most common cancer in the UK, yet human bladder carcinogenesis remains p...
Bladder cancer (BC) constitutes approximately 2% of all spontaneously occurring cancers in dogs. It ...
The therapeutic use of stem cells and tissue engineering techniques are emerging in urology. Here, s...
Urological malignancies, including prostate and bladder carcinoma, represent a major clinical proble...
Each year more than 65,000 people are diagnosed with urinary bladder cancer, and more than 14,000 pe...
Urotelial cancer, is a common malignancy in the worldwide, is an important contributor to the overal...
Bladder cancer is a common malignancy that has a relatively poor outcome. Lack of culture models for...